Suppression of mesenchymal phenotype in inflammatory breast cancer by EGFR tyrosine kinase inhibitor erlotinib: a novel approach to suppressing metastasis.
Year: 2009
Type: conference-abstract
Source: Cancer Research
Authors: NT Ueno, A Kazansky, TA LaFortune, A Lucci, S Krishnamurthy, M Hung, GN Hortobagyi, W Woodward, JM Reuben, F Robertson, M Cristofanilli, D Zhang
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2329186408